FDA highlights ideas to improve time to market

06/4/2007 | Deseret News (Salt Lake City), The

The FDA's Critical Path Initiative aims to speed drugs and medical devices from concept to cure and sees personalized medicine as one way to cut R&D costs and time. "We are on the verge of the most profound transformation in the history of medicine," FDA commissioner Dr. Andrew von Eschenbach said.

View Full Article in:

Deseret News (Salt Lake City), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Paralegal, Legal-Regulatory
Confidential
Piscataway, NJ